ChartRow logo
ChartRow
Investing Charts
ZTS
Zoetis Inc.Stock · HealthcareS&P 500 0.1%
$75.35+$0.78 (+1.05%)as of market close, Jul 24, 2026
CompareLLYUNHJNJABBVISRGABT

ZTS financial statements

The full income statement, balance sheet, and cash-flow statement for Zoetis Inc. (ZTS), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

As-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue
9.47B
YoY+2.3%
9.26B
YoY+8.3%
8.54B
YoY+5.7%
8.08B
YoY+3.9%
7.78B
YoY+16.5%
Cost of revenue
2.67B
YoY-1.9%
2.72B
YoY+6.2%
2.56B
YoY+4.4%
2.45B
YoY+6.6%
2.30B
YoY+12.0%
Research & development
698M
YoY+1.7%
686M
YoY+11.7%
614M
YoY+13.9%
539M
YoY+6.1%
508M
YoY+9.7%
Selling, general & administrative
2.38B
YoY+2.6%
2.32B
YoY+7.8%
2.15B
YoY+7.1%
2.01B
YoY+0.4%
2.00B
YoY+15.9%
Restructuring
49.0M
YoY+14.0%
43.0M
YoY-6.5%
46.0M
YoY+666.7%
6.00M
YoY-81.8%
33.0M
YoY+312.5%
Amortization of intangibles
157M
YoY-7.6%
170M
YoY-8.1%
185M
YoY-4.1%
193M
YoY-5.4%
204M
YoY-11.3%
Interest expense
222M
YoY-1.3%
225M
YoY-5.9%
239M
YoY+8.1%
221M
YoY-1.3%
224M
YoY-3.0%
Other non-operating income
-6.00M
YoY-50.0%
-4.00M
YoY-100.0%
-2.00M
YoY-114.3%
14.0M
YoY+450.0%
-4.00M
YoY+20.0%
Pre-tax income
3.36B
YoY+7.2%
3.13B
YoY+6.7%
2.94B
YoY+10.5%
2.66B
YoY+6.8%
2.49B
YoY+24.6%
Income tax
687M
YoY+7.8%
637M
YoY+6.9%
596M
YoY+9.4%
545M
YoY+20.0%
454M
YoY+26.1%
2.67B
YoY+7.5%
2.49B
YoY+6.1%
2.34B
YoY+10.9%
2.11B
YoY+3.8%
2.04B
YoY+24.4%
$6.02
YoY+10.1%
$5.47
YoY+7.9%
$5.07
YoY+12.9%
$4.49
YoY+5.2%
$4.27
YoY+24.9%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
6.77B
YoY+13.1%
5.99B
YoY-5.6%
6.34B
YoY-15.5%
7.51B
YoY+8.3%
6.93B
YoY+4.8%
15.5B
YoY+8.8%
14.2B
YoY-0.3%
14.3B
YoY-4.3%
14.9B
YoY+7.4%
13.9B
YoY+2.1%
2.17B
YoY-36.3%
3.41B
YoY+80.6%
1.89B
YoY-40.4%
3.17B
YoY+76.2%
1.80B
YoY-17.2%
12.1B
YoY+27.5%
9.47B
YoY+1.9%
9.29B
YoY-11.7%
10.5B
YoY+12.5%
9.36B
YoY-4.9%
3.42B
YoY-28.4%
4.77B
YoY-4.5%
5.00B
YoY+13.4%
4.41B
YoY-3.0%
4.54B
YoY+20.5%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
2.90B
YoY-1.7%
2.95B
YoY+25.5%
2.35B
YoY+23.1%
1.91B
YoY-13.6%
2.21B
YoY+4.1%
-748M
YoY-137.5%
-315M
YoY+59.5%
-777M
YoY+12.0%
-883M
YoY-92.8%
-458M
YoY+19.9%
-1.87B
YoY+29.7%
-2.66B
YoY+14.4%
-3.11B
YoY-243.9%
-904M
YoY+51.5%
-1.86B
YoY-1613.8%
FX effect on cash
39.0M
YoY+221.9%
-32.0M
YoY-357.1%
-7.00M
YoY+75.9%
-29.0M
YoY-141.7%
-12.0M
YoY-71.4%
Net change in cash
325M
YoY+701.9%
-54.0M
YoY+96.5%
-1.54B
YoY-1704.2%
96.0M
YoY+180.7%
-119M
YoY-107.1%
Interest paid
261M
YoY-4.7%
274M
YoY-7.1%
295M
YoY+21.9%
242M
YoY-4.3%
253M
YoY-1.6%
Income taxes paid
715M
YoY-19.8%
892M
YoY+18.3%
754M
YoY+18.2%
638M
YoY+16.4%
548M
YoY+31.1%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap
53.1B
YoY-27.2%
73.0B
YoY-19.5%
90.6B
YoY+32.7%
68.3B
YoY-40.7%
115B
YoY+46.5%
P/E
19.9×
YoY-32.3%
29.3×
YoY-26.2%
39.7×
YoY+20.3%
33.0×
YoY-41.6%
56.5×
YoY+17.8%
P/S
5.6×
YoY-28.8%
7.9×
YoY-27.2%
10.8×
YoY+26.9%
8.5×
YoY-42.4%
14.8×
YoY+25.7%
P/B
15.6×
YoY+1.7%
15.3×
YoY-14.3%
17.8×
YoY+21.8%
14.6×
YoY-42.2%
25.4×
YoY+21.5%
P/FCF
23.3×
YoY-26.7%
31.7×
YoY-47.7%
60.7×
YoY+12.7%
53.9×
YoY-18.7%
66.3×
YoY+41.1%
5.0%
YoY+47.7%
3.4%
YoY+35.4%
2.5%
YoY-16.9%
3.0%
YoY+71.1%
1.8%
YoY-15.1%
4.3%
YoY+36.5%
3.1%
YoY+91.3%
1.6%
YoY-11.2%
1.9%
YoY+23.1%
1.5%
YoY-29.2%
1.6%
YoY+46.4%
1.1%
YoY+39.7%
0.79%
YoY-14.4%
0.92%
YoY+109.1%
0.44%
YoY-14.2%
Source filing10-K10-K10-K10-K10-K

About this data

Source: ZTS's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all ZTS filings on SEC EDGAR → Not investment advice.